DrugPatentWatch Database Preview
Profile for United States of America Patent: 2012059023
US Patent Family Members and Approved Drugs for United States of America Patent: 2012059023
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Jun 1, 2025 | Salix Pharms | XIFAXAN | rifaximin |
➤ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
➤ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
➤ Sign Up | Jun 19, 2024 | Salix Pharms | XIFAXAN | rifaximin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |